Literature DB >> 14678637

Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections.

R Russo1, F Laguna, R López-Vélez, F J Medrano, E Rosenthal, B Cacopardo, L Nigro.   

Abstract

Cases of visceral leishmaniasis (VL) in HIV-positive individuals have been reported from most areas of the world where the geographical distributions of the two infections overlap. The majority of the co-infected cases that have been recorded, however, live around the Mediterranean basin. In these subjects, the length of the incubation period of VL is presumably very short, particularly in those who have severe immunodepression. At diagnosis, almost all cases of VL/HIV co-infection have been found to have fewer than 200 CD4+ cells/microl blood, and about 50% meet the AIDS-defining criteria during their first episode of VL. The clinical manifestations of VL in HIV-infected individuals may be similar to those seen in HIV-negative cases; fever, pancytopenia and hepato-splenomegaly, for example, are found in 75% of all the HIV-positive cases. Following the dissemination of the parasites, however, the HIV-positive cases may develop unusual, multi-organ pathology. Almost all the cases of co-infection are very prone to VL relapses, even after carefully managed antileishmanial treatment. The opportunistic infections that are often seen in HIV-positives frequently develop during VL episodes, the signs and symptoms of the leishmaniasis then confusingly overlapping with those of the other infections.

Entities:  

Mesh:

Year:  2003        PMID: 14678637     DOI: 10.1179/000349803225002570

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  19 in total

Review 1.  Diagnosis of visceral leishmaniasis: developments over the last decade.

Authors:  Gurumurthy Srividya; Arpita Kulshrestha; Ruchi Singh; Poonam Salotra
Journal:  Parasitol Res       Date:  2011-11-09       Impact factor: 2.289

2.  Atypical lesions as a sign of cutaneous dissemination of visceral leishmaniasis in a human immunodeficiency virus-positive patient simultaneously infected by two viscerotropic Leishmania species.

Authors:  Joanna R Santos-Oliveira; Alda M Da-Cruz; Lucy H S Pires; Elisa Cupolillo; Katrin Kuhls; Carmem B W Giacoia-Gripp; Manoel P Oliveira-Neto
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

3.  Visceral leishmaniasis in immunosuppressed Caucasian patient.

Authors:  Muhammad Toqeer; Nadeem Rahman; Mark W Whitehead; Diana Lockwood
Journal:  BMJ Case Rep       Date:  2012-05-08

4.  Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation.

Authors:  S Rama Iñiguez; M A Dea-Ayuela; J A Sanchez-Brunete; J J Torrado; J M Alunda; F Bolas-Fernández
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

5.  Comparison of parasitological, serological, and molecular tests for visceral leishmaniasis in HIV-infected patients: a cross-sectional delayed-type study.

Authors:  Gláucia Fernandes Cota; Marcos Roberto de Sousa; Betânia Mara de Freitas Nogueira; Luciana Inácia Gomes; Edward Oliveira; Tália Santana Machado Assis; Andréa Laender Pessoa de Mendonça; Bruna Fernandes Pinto; Juliana Wilke Saliba; Ana Rabello
Journal:  Am J Trop Med Hyg       Date:  2013-07-08       Impact factor: 2.345

6.  An immunoproteomic approach to identifying immunoreactive proteins in Leishmania infantum amastigotes using sera of dogs infected with canine visceral leishmaniasis.

Authors:  Sajad Rashidi; Zahra Mojtahedi; Bahador Shahriari; Kurosh Kalantar; Ghasem Ghalamfarsa; Mehdi Mohebali; Gholamreza Hatam
Journal:  Pathog Glob Health       Date:  2019-05-17       Impact factor: 2.894

Review 7.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

8.  Five-year retrospective Italian multicenter study of visceral leishmaniasis treatment.

Authors:  Francesco Di Masi; Tamara Ursini; Maria Donata Iannece; Leonardo Chianura; Francesco Baldasso; Giuseppe Foti; Pietro Di Gregorio; Angelo Casabianca; Nunzio Storaci; Luciano Nigro; Claudia Colomba; Maria Grazia Marazzi; Giovanni Todaro; Giacinta Tordini; Giacomo Zanelli; Giovanni Cenderello; Nicola Acone; Ennio Polilli; Simona Migliore; Paolo Almi; Eligio Pizzigallo; Evangelista Sagnelli; Francesco Mazzotta; Rosario Russo; Lamberto Manzoli; Giustino Parruti
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

9.  Asymptomatic carriers of Leishmania infantum in patients infected with human immunodeficiency virus (HIV) in Morocco.

Authors:  M Echchakery; J Nieto; S Boussaa; N El Fajali; S Ortega; K Souhail; H Aajly; C Chicharro; E Carrillo; J Moreno; A Boumezzough
Journal:  Parasitol Res       Date:  2018-02-24       Impact factor: 2.289

10.  Comparison of Three In-House Real PCR Assays Targeting Kinetoplast DNA, the Small Subunit Ribosomal RNA Gene and the Glucose-6-Phosphate Isomerase Gene for the Detection of Leishmania spp. in Human Serum.

Authors:  Konstantin Tanida; Carsten Balczun; Andreas Hahn; Alexandra Veit; Beatrice Nickel; Sven Poppert; Patrick Leander Scheid; Ralf Matthias Hagen; Hagen Frickmann; Ulrike Loderstädt; Egbert Tannich
Journal:  Pathogens       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.